رجوع
نطاق اليوم
KWD 11.04
KWD 12.01
نطاق 52 أسبوعًا
KWD 6.92
KWD 18.69
حجم التداول
1,230,502
متوسط 50 يوم / 200 يوم
KWD 12.31
/
KWD 11.72
الإغلاق السابق
KWD 12.05
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -9.5 | 0.4 |
| P/B | 1.4 | 2.9 |
| ROE % | -14.0 | 3.9 |
| Net Margin % | -73.2 | 3.8 |
| Rev Growth 5Y % | -17.8 | 10.0 |
| D/E | 0.3 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 28.750
+141.8%
Low: KWD 18.000
High: KWD 42.000
ربحية السهم المستقبلية
-KWD 2.880
الإيرادات المقدّرة
120 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 0.044
-KWD 0.003 – KWD 0.113
|
530 M | 3 |
| FY2029 |
-KWD 1.461
-KWD 3.718 – KWD 0.101
|
270 M | 3 |
| FY2028 |
-KWD 2.701
-KWD 4.080 – -KWD 0.750
|
170 M | 9 |
النقاط الرئيسية
Revenue declined -17.80% annually over 5 years
Debt/Equity of 0.30 — conservative balance sheet
Negative free cash flow of -138.27M
PEG of 0.19 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 31.45%
Capital efficient — spends only 2.51% of revenue on capex
النمو
Revenue Growth (5Y)
-17.80%
Revenue (1Y)13.65%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-14.00%
ROIC-16.17%
Net Margin-73.20%
Op. Margin-141.35%
الأمان
Debt / Equity
0.30
Current Ratio6.25
Interest Coverage-5.56
التقييم
P/E Ratio
-9.49
P/B Ratio1.37
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.65% | Revenue Growth (3Y) | -15.20% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -17.80% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 125.58M | Net Income (TTM) | -91.92M |
| ROE | -14.00% | ROA | -10.50% |
| Gross Margin | 91.63% | Operating Margin | -141.35% |
| Net Margin | -73.20% | Free Cash Flow (TTM) | -138.27M |
| ROIC | -16.17% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.30 | Current Ratio | 6.25 |
| Interest Coverage | -5.56 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -9.49 | P/B Ratio | 1.37 |
| P/S Ratio | 6.94 | PEG Ratio | 0.19 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 872.00M | Enterprise Value | 1.01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 125.58M | 110.49M | 174.62M | 164.58M | 275.11M |
| Net Income | -91.92M | -232.62M | -133.13M | -55.18M | 82.63M |
| EPS (Diluted) | -1.24 | -3.58 | -2.08 | -0.93 | 1.37 |
| Gross Profit | 115.06M | 110.49M | 174.62M | 164.58M | 275.11M |
| Operating Income | -177.50M | -178.41M | -132.36M | -82.47M | 43.77M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 875.50M | 951.95M | 952.69M | 846.27M | 838.21M |
| Total Liabilities | 239.91M | 277.92M | 283.56M | 118.77M | 104.71M |
| Shareholders' Equity | 635.59M | 677.61M | 668.80M | 727.50M | 733.50M |
| Total Debt | 187.75M | 231.95M | 83.43M | 59.63M | 33.97M |
| Cash & Equivalents | 54.07M | 40.88M | 53.79M | 53.94M | 143.48M |
| Current Assets | 599.82M | 577.60M | 623.16M | 675.34M | 424.37M |
| Current Liabilities | 95.91M | 87.43M | 84.71M | 63.84M | 70.74M |